CLEC10A and prostate carcinoma: Exploring HML-2 mRNA levels in prostate cancer specimens revealed significantly elevated expression of HERV-K_22q11.23 5’LTR-gag and env in 45 prostate cancer tumour samples versus 11 benign prostate tissues.